Clinical

Dataset Information

0

CS-1008 Used With Irinotecan Versus Irinotecan Alone in Subjects With Metastatic Colorectal Carcinoma Who Failed First-line Treatment With Oxaliplatin


ABSTRACT: The purpose of this study is to determine the effect of CS-1008 in combination with irinotecan compared to irinotecan alone on Progression-Free Survival (PFS) in subjects with metastatic or advanced colorectal cancer (CRC) who have failed oxaliplatin-based first-line treatment.

DISEASE(S): Metastatic Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2077407 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| 2089205 | ecrin-mdr-crc
| 2096559 | ecrin-mdr-crc
| PRJNA777368 | ENA
2014-07-18 | GSE59501 | GEO
| PRJNA188498 | ENA
2019-05-03 | GSE72484 | GEO
2014-07-18 | E-GEOD-59501 | biostudies-arrayexpress
2012-07-01 | GSE29002 | GEO
2012-06-30 | E-GEOD-29002 | biostudies-arrayexpress
| PRJNA66287 | ENA